Browse abstracts for all scientific posters that have been presented at the AAPP Annual Meeting.
Use the search box to quickly locate an abstract by any data in the column, including "PGY2"! The site search provides full-text search of all abstracts that have been presented at the AAPP Annual Meeting over the years.
Browse: 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025
| Title | Type | Presenter | Session | ||
|---|---|---|---|---|---|
 | A comprehensive review of ziprasidone and the QTc Interval | Encore Presentation | |||
| A Cross Country Study of The Effect of Three Dibenzodiazepines: Clozapine, Quetiapine And Olanzepine On Thyroid Function In Patients With Schizophrenia | Work in Progress | |||
| A POOLED ANALYSIS OF THE EFFECTS OF ASENAPINE ON THE PERSISTENT NEGATIVE SYMPTOMS OF SCHIZOPHRENIA | Encore Presentation | |||
| A Review of Behavioral Health Inpatients Discharged on Two or More Antipsychotic Medications | Work in Progress | |||
| Abnormal Triiodothyronine Levels in a 12 Year Old on Lithium | Encore Presentation | |||
| ADHERENCE AND CLINICAL OUTCOME OF METABOLIC MONITORING IN PSYCHIATRIC PATIENTS TRANSITIONING FROM AN INPATIENT TO OUTPATIENT SETTING | Work in Progress | |||
| Adherence to Selective Serotonin Reuptake Inhibitors in OEF/OIF Veterans with Mental Health Disorders: The Impact of Pharmacist Services | Work in Progress | |||
| AGRANULOCYTOSIS ASSOCIATED WITH PSYCHOTROPIC MEDICATIONS: A FATAL CASE | Therapeutic Case Report | |||
| ALL CAUSE MORTALITY IN OLDER VETERANS WITH DEMENTIA ON LONG-TERM ATYPICAL ANTIPSYCHOTICS | Original Research | |||
| An Evaluation of the Comparative Risks of Atypical Antipsychotics used for Augmentation in Major Depressive Disorder (MDD) | Original Research | |||
| An Instrument for Measuring Pharmacist and Physician Attitudes Toward Collaboration: Preliminary Psychometric Data | Encore Presentation | |||
| Anticholinergic Burden and Risk of Mechanical Falls in an Elderly Asian American Community Dwelling Population | Original Research | |||
| ANTIPSYCHOTIC MEDICATIONS AND THE DEVELOPMENT OF PNEUMONIA IN PERSONS DIAGNOSED WITH SCHIZOPHRENIA | Original Research | |||
| Antipsychotic Treatment and Tobacco Craving in People With Schizophrenia | Encore Presentation | |||
| ARE PROVIDERS DOCUMENTING THE EFFICACY OF ARIPIPRAZOLE FOR ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER AFTER 3 MONTHS OF TREATMENT? | Work in Progress | |||
| ARIPIPRAZOLE-INDUCED HYPERTENSIVE CRISIS: A CASE SERIES | Therapeutic Case Report | |||
| ARIPIPRAZOLE: A REVIEW FOR EFFICACY IN METHAMPHETAMINE USE COMORBIDITIES IN TWO PSYCHIATRIC PATIENT POPULATIONS | Work in Progress | |||
| ASSESSMENT OF ADHERENCE WITH METABOLIC MONITORING BEFORE AND AFTER IMPLEMENTATION OF A PHARMACY-DRIVEN COMPUTERIZED METABOLIC MONITORING DATABASE | Work in Progress | |||
| Assessment of Medication Adherence in an Immigrant/Refugee Psychiatric Patient Population | Work in Progress | |||
| Assessment of Prophylactic Clozapine Levels in Stable Outpatients with Schizophrenia and Schizoaffective Disorder | Work in Progress | |||
| Assessment of Psychotropic Drug Abuse in an Adolescent Substance Dependent Population and Evaluation of Associated Prescriber Perceptions | Work in Progress | |||
 | Assessment of Tobacco Craving in Smokers with Schizophrenia using Virtual Reality | Encore Presentation | |||
| Association between LEP -2548 (rs7799039) and obesity during antipsychotic treatment | Encore Presentation | |||
| Atomoxetine in adults with attention-deficit/hyperactivity disorder: A 24-week, randomized, double-blind, placebo-controlled trial | Encore Presentation | |||
| Attitudes and expectations of individuals with schizophrenia and schizoaffective disorder toward pharmacists. | Original Research | |||
| ATYPICAL ANTIPSYCHOTIC POLYPHARMACY: ARE SAFETY AND ECONOMIC CONCERNS REALLY A REASON TO AVOID ATYPICAL ANTIPSYCHOTIC COMBINATION THERAPY? | Work in Progress | |||
| Buprenorphine-naloxone for the office-based treatment of opiate addiction in patients with psychiatric co-morbidities | Work in Progress | |||
| Cardiometabolic Impact of Second Generation Antipsychotics in the Pediatric Population: Implications for Future Prescribing Practices of Antipsychotics in Children | Work in Progress | |||
| Cardiovascular Risk Profile of Patients with Severe Mental Illness | Original Research | |||
| CHANGE IN STUDENTS' KNOWLEDGE AND ATTITUDES AFTER PARTICIPATING IN AN ALCOHOL AND OTHER DRUG DEPENDENCIES ELECTIVE | Encore Presentation | |||
| Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder | Work in Progress | |||
| Clinical Management of Metabolic Syndrome: Does Mental Illness impact care? | Work in Progress | |||
| CLOZAPINE POINT OF CARE TESTING AT AN INDEPENDENT MENTAL HEALTH PHARMACY | Innovative Practices | |||
| Clozapine-induced hiccups and facial tics in a schizophrenic patient : a case report | Therapeutic Case Report | |||
| COLLABORATIVE DRUG THERAPY MANAGEMENT FOR BUPRENORPHINE- MAINTAINED PATIENTS | Innovative Practices | |||
| Comparison of hospitalisation time of schizophrenic patients exposed and not exposed to therapeutic drug monitoring of clozapine | Original Research | |||
| Comparison of Long Acting Antipsychotic Injections to the Oral Equivalents and the Impact on Recidivism | Work in Progress | |||
| Considering Cytochrome P450 Genotyping Results During Clinical Psychopharmacology Consultation | Innovative Practices | |||
| CPNP Student Chapter fills a void for students interested in psychiatric pharmacy | Innovative Practices | |||
| Creation and Implementation of a Psychopharmacology Consult Team to Improve Outcomes in the Severely Mentally Ill Population | Work in Progress | |||
| DESIGN AND IMPLEMENTATION OF A CLINICAL PHARMACIST MANAGED METABOLIC SYNDROME CLINIC IN A MENTAL HEALTH SETTING | Work in Progress | |||
| Developing an interdisciplinary pharmacogenomic treatment approach to reduce medication burden and improve subject outcomes | Work in Progress | |||
| Development of Psychotropic Medication Utilization Parameters for Foster Children. | Innovative Practices | |||
| DISASTER IMPACT ON THE PSYCHIATRIC PATIENT: A PREPAREDNESS TOOLKIT | Innovative Practices | |||
| Double-Blind, Placebo-Controlled Efficacy and Safety Study of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder | Encore Presentation | |||
| Drug assay monitoring in psychiatric inpatients: evaluation of a pharmacist verification process for lithium and valproic acid laboratory orders | Work in Progress | |||
| Drug Utilization Evaluation of Patient Variables Leading to the Administration of Olanzapine Orally-Disintegrating Tablets for Acute Agitation in a Community Hospital | Encore Presentation | |||
| EARLY IMPROVEMENT PREDICTS LATER OUTCOME IN MANIC OR MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER: POST HOC ANALYSES OF ASENAPINE STUDIES | Original Research | |||
| Effect of Adjunctive Aripiprazole on Domains of Functioning in Patients with Major Depressive Disorder: a Pooled Analysis of Three Clinical Trials | Encore Presentation | |||
| EFFECT OF CLINICAL PHARMACIST INVOLVEMENT WITH THE MENTAL HEALTH INTENSIVE CASE MANAGEMENT (MHICM) TEAM AT VA SAN DIEGO HEALTHCARE SYSTEM | Work in Progress | |||
| Effect of Duloxetine 30mg and 60mg on the Pupillary Light Reflex as Compared with Placebo | Encore Presentation | |||
| EFFECT OF FOOD ON THE PHARMACOKINETICS OF SUBLINGUAL ASENAPINE | Encore Presentation | |||
| Effect of prior antipsychotic exposure on weight gain during aripiprazole treatment of irritability associated with autistic disorder | Encore Presentation | |||
| Effects of Pharmacist Quarterly Drug Regimen Reviews on Physician Compliance with Recommended Laboratory Monitoring Parameters for Psychotropic Medications at a State Supported Living Center | Work in Progress | |||
| Efficacy of Memantine by Baseline Disease Severity: Post-hoc Analysis of Pooled Trials in Patients with Mild to Moderate Alzheimers Disease | Encore Presentation | |||
| Efficacy of Memantine in Moderate to Severe Alzheimers Disease: Time-to-Event Analysis in a Pooled Population | Encore Presentation | |||
| Endothelial Functioning and Omega 3 Fatty Acids in Schizophrenia Subjects Receiving Antipsychotics | Encore Presentation | |||
| EVALUATING AND PREVENTING MEDICATION ERRORS IN A MENTAL HEALTH FACILITY-WHAT IS THE PHARMACIST ROLE? | Work in Progress | |||
| Evaluating the Effect of Concomitant Medications With Clozapine | Original Research | |||
| Evaluation of antidepressant prescribing and management between primary care physicians and psychiatrists and the adherence to treatment guidelines | Work in Progress | |||
| EVALUATION OF ARIPIPRAZOLE UTILIZATION FOR AUGMENTATION OF ANTIDEPRESSANT PHARMACOTHERAPY | Work in Progress | |||
| Evaluation of Delirium Risk Factors in Patients Undergoing Acute Abdominal Transplants | Work in Progress | |||
| Evaluation of Fall Rates and Medication Regimens for Patients in an Inpatient Psychiatric versus General Medical-Surgical Ward | Work in Progress | |||
| Evaluation of perphenazine use in a veteran population | Work in Progress | |||
| Evaluation of schizophrenic, schizoaffective, and bipolar patients with exposure to sexual and/or physical abuse and its effect on treatment: a retrospective review | Work in Progress | |||
| EVALUATION OF SEXUAL FUNCTION IN OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH DESVENLAFAXINE OR PLACEBO | Encore Presentation | |||
| EVALUATION OF THE MANAGEMENT OF ADVERSE EVENTS ASSOCIATED WITH ALPHA-2-AGONISTS FOR POSTTRAUMATIC STRESS DISORDER IN CHILDREN AND ADOSESCENTS | Work in Progress | |||
| Evaluation of Virtual Patient Cases in a Psychiatry Elective Seminar Course | Work in Progress | |||
| Facilitating the continuum of care for patients unable to take oral psychotropic medications: A case report of transdermal venlafaxine | Therapeutic Case Report | |||
| Fatal Acute Hepatotoxicity Associated with Valproate Initiation in an Adult | Therapeutic Case Report | |||
| Frequency and Type of Interventions Aimed at Reducing Cardiovascular Risk in Mental Health Patients in an Urban Teaching Hospital | Original Research | |||
| Genetic and Environmental Risk Factors for Postpartum Depression | Encore Presentation | |||
| GRAVES’ HYPERTHYROIDISM-INDUCED PSYCHOSIS TREATED WITH ARIPIPRAZOLE- A CASE REPORT | Therapeutic Case Report | |||
| HEMATOLOGICAL EFFECTS OF VALPROATE IN A SKILLED NURSING POPULATION | Work in Progress | |||
 | Iloperidone in the Treatment of Seriously Mentally Ill Patients with Treatment-Refractory Schizophrenia and Schizoaffective Disorder: A Case Series | Therapeutic Case Report | |||
| Impact of Educational Interventions on Insight and Attitudes toward Medication in Psychiatric Inpatients | Original Research | |||
| Impact of Pharmacist's Medication Monitoring Program on Antipsychotic Prescribing in a Large Outpatient County Organization | Original Research | |||
| IMPACT OF PRETREATMENT WITH AMOBARBITAL ON ELECTROCONVULSIVE THERAPY OUTCOMES | Work in Progress | |||
| Impact of the CATIE trial on antipsychotic prescribing patterns at a state psychiatric facility | Original Research | |||
| IMPROVING MENTAL HEALTH OUTCOMES IN VETERANS THROUGH ACADEMIC DETAILING | Innovative Practices | |||
| INCIDENCE, ONSET, AND DURATION OF TREATMENT-EMERGENT SOMNOLENCE WITH ASENAPINE IN PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER | Original Research | |||
| INCORPORATION OF CLINICAL PHARMACY INTO AN INTEGRATED BEHAVIORAL HEALTH SERVICE IN A FAMILY MEDICINE CLINIC | Work in Progress | |||
| INCREASED PATIENT RESPONSE TO INTRAMUSCULAR HALOPERIDOL DECANOATE FOLLOWING A CHANGE IN NEEDLE LENGTH | Therapeutic Case Report | |||
| Induction of Drug Efflux Protein Expression by Venlafaxine but not Desvenlafaxine | Encore Presentation | |||
| LEADERSHIP DEVELOPMENT THROUGH A BOOK CLUB USING THE FIVE DYSFUNCTIONS OF A TEAM | Work in Progress | |||
| Long-Acting Injectable Risperidone versus Oral Risperidone: A Comparison of Recidivism | Work in Progress | |||
| Long-term comparative effectiveness and safety of duloxetine vs. venlafaxine XR in veterans with major depressive disorder | Work in Progress | |||
| Medication Adherence, Lipid and Glycemic Control in Patients with Psychotic Disorders Compared to Patients without Psychiatric Illness Receiving Care in a Veterans Affairs Medical System | Original Research | |||
| META-ANALYSES OF THE EFFICACY OF ASENAPINE VERSUS PLACEBO IN BIPOLAR I DISORDER AS MONOTHERAPY AND ADJUNCT THERAPY COMPARED WITH OTHER ATYPICAL ANTIPSYCHOTICS | Encore Presentation | |||
| META-ANALYSIS OF THE EFFICACY OF ASENAPINE FOR ACUTE SCHIZOPHRENIA: COMPARISONS WITH PLACEBO AND OTHER ATYPICAL ANTIPSYCHOTICS | Encore Presentation | |||
| Metabolic adverse effects of second generation antipsychotics in an elderly veteran population | Work in Progress | |||
| Metabolic Monitoring and Second Generation Antipsychotic Use: Does Indication Matter? | Work in Progress | |||
| METABOLIC SYNDROME MONITORING PROGRAM: A CLINICAL PROGRAM TO SCREEN PATIENTS FOR METABOLIC SYNDROME IN A STATE PSYCIATRIC HOSPITAL | Work in Progress | |||
| Nova Southeastern CPNP Collegiate Chapter: Activities and Development | Innovative Practices | |||
| Opiate Use for Chronic Non-malignant Pain | Original Research | |||
| Pediatricians' Treatment of Children and Adolescents with Major Depressive Disorder | Original Research | |||
| Pharmacist Discharge Counseling: Effects on Discharge Medication Errors on a Behavioral Medicine Unit | Work in Progress | |||
| Pharmacokinetics of Coadministration of Guanfacine Extended Release and Lisdexamfetamine Dimesylate | Original Research | |||
| Pharmacokinetics of Coadministration of Guanfacine Extended Release and Methylphenidate Extended Release | Original Research | |||
| Pharmacologic Management of Intermittent Explosive Disorder with Multiple Comorbidities in an 8 year-old male | Therapeutic Case Report | |||
| Pharmacotherapeutic Regimens in Patients with Post Traumatic Stress Disorder and Co-morbid Mild Traumatic Brain Injury | Original Research | |||
| POOLED ANALYSIS OF ASENAPINE POPULATION PHARMACOKINETICS IN PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER | Encore Presentation | |||
| Preliminary data of metabolic risk at 6-months in subjects on antipsychotic agents: A 12-month randomized multi-centered trial. | Work in Progress | |||
| Prescribing Patterns in a Corrections Population with Bipolar Disorder | Encore Presentation | |||
| Primary Care Physician Mental Health Hotline | Innovative Practices | |||
| PROBABLE QUETIAPINE-MEDIATED PROLONGATION OF THE QT INTERVAL | Encore Presentation | |||
| Psychotropic Medication Adherence: Development of an Inmate Interview Process | Work in Progress | |||
| Rasagiline and Antidepressant Use in Patients With Parkinson Disease: Assessing the Occurrence of Serotonin Toxicity | Original Research | |||
| Retrospective evaluation of metabolic outcomes during treatment with paliperidone and the effects of coprescribed lipid lowering agents | Encore Presentation | |||
| Retrospective Evaluation of the Effectiveness of Paliperidone Palmitate Injection in an Acute Care 33 Bed Adult Inpatient Psychiatric Hospital. | Original Research | |||
| Retrospective Review of Neuroleptic Malignant Syndrome with Atypical Antipsychotics | Work in Progress | |||
| RISK OF CARDIOVASCULAR MORBIDITY AND SUDDEN DEATH WITH RISPERIDONE AND PALIPERIDONE TREATMENT: ANALYSIS OF 64 RANDOMIZED, DOUBLE-BLIND TRIALS | Original Research | |||
| Risk of Falls Associated with Hyponatremia | Work in Progress | |||
| Risperidone-Associated Prolactin Elevation And Markers Of Bone Turnover Early In Treatment | Therapeutic Case Report | |||
| Safety and Tolerability of Aripiprazole in the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (6-17 years old): Results from a 52-week Open-Label Study | Encore Presentation | |||
| Schizophrenic Patients: Applying Medication Instructions | Work in Progress | |||
| SEVERE HYPOTHYROIDISM PRESENTING AS PSYCHOSIS: A CASE OF MYXEDEMA MADNESS | Therapeutic Case Report | |||
| Single Pulse Transcranial Magnetic Stimulation (TMS) Augmentation of Motor Response Using fMRI-Guided Neuronavigation | Encore Presentation | |||
| Study of Rehospitalization Rates of Schizophrenic Patients Discharged on Typical versus Atypical Antipsychotics | Encore Presentation | |||
| Survey of Experiential Clerkship Opportunity in Substance Dependence | Work in Progress | |||
| THE EFFECT OF DESVENLAFAXINE ON COGNITIVE FUNCTIONING IN EMPLOYED OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER | Encore Presentation | |||
| THE EFFECTS OF SUBUNIT STOICHIOMETRY ON CHANNEL RESPONSES TO LIGAND EXPOSURE IN SH-EP1 CELLS EXPRESSING a4b2 NEURONAL NICOTINIC RECEPTORS | Work in Progress | |||
| The Efficacy of Melatonin for Sleep Disturbances in Patients with Substance-Related Disorders | Work in Progress | |||
| The Efficacy of Melatonin for the Treatment of Sleep Disturbances on a Psychosocial Care Unit | Work in Progress | |||
| The impact Analysis of Non Formulary Drug request in a state psychiatric teaching hospital | Work in Progress | |||
| The Impact of a Pharmacist Assisted Clinic upon Medication Adherence and Quality of Life in Mental Health Patients | Innovative Practices | |||
| THE IMPACT OF DEPRESSION ON THE SUSTAINED VIRAL RESPONSE OF INTERFERON TREATMENT WITH HEPATITIS C | Work in Progress | |||
| The impact of initial drug of abuse on long-term abstinence in patients utilizing buprenorphine/naloxone therapy | Work in Progress | |||
| The Management of Antipsychotic Treatment Discontinuation and Interruptions using Model-Based Stimulations | Original Research | |||
| The speed of effects of atypical antipsychotic agents on cholesterol. | Therapeutic Case Report | |||
| TREATMENT OF SCHIZOPHRENIA AND CO-MORBID DIPHENHYDRAMINE DEPENDENCE WITH CLOZAPINE: A CASE REPORT | Therapeutic Case Report | |||
| Treatment Outcomes Across a Spectrum of Disease Severity in Subjects With Bipolar I Disorder Treated With Ziprasidone Plus a Mood Stabilizer | Encore Presentation | |||
| Utilizing 4th Year Pharmacy Students as the Primary Pharmacy Members within Mental Health Interdisciplinary Teams | Innovative Practices | |||
| WEIGHT CHANGE AND METABOLIC EFFECTS OF ASENAPINE IN PLACEBO- OR OLANZAPINE-CONTROLLED STUDIES | Encore Presentation | |||
| Weight Gain and Metabolic Changes in Studies of Aripiprazole for the Treatment of Pediatric Bipolar I Disorder and Adolescent Schizophrenia | Encore Presentation |